Humana Inc (HUM)
Humana Inc. provides medical and specialty insurance products in the United States. It operates in two segments, Insurance and CenterWell. The Insurance segment offers individual Medicare Advantage products, including health insurance benefits, including wellness programs, chronic care management, and care coordination; individual Medicare stand-alone prescription drug products (PDP); group Medicare advantage and Medicare stand-alone PDP; Medicare supplements; specialty and ancillary insurance comprising dental, vision, life and disability; and administrative services to arrange health care services for active-duty and retired military personnel and dependents, as well as pharmacy benefit managers. Its CenterWell segment operates full-service, value-based senior focused primary care centers under the Conviva Senior Primary Care and CenterWell Senior Primary Care brands; a management services organization; CenterWell Home Health, a home health provider; and OneHome, which manages post-acute patient needs, as well as provides pharmacy and hospice solutions. The company was formerly known as Extendicare Inc. and changed its name to Humana Inc. in April 1974. Humana Inc. was founded in 1961 and is headquartered in Louisville, Kentucky.
- Symbol
- HUM
- Exchange
- NYSE
- Sector
- Healthcare
- Industry
- Healthcare Plans
- Market cap
- $45.00B
- 52 week range
- 163.11 - 428.88
Valuation
- Share price
- $374.78 (close of 2026-09-23)
- P/E (TTM)
- 39.83x
- Price to book
- 2.41x
- Price to free cash flow
- 35.37x
- Enterprise value
- $37.02B
- Book value per share
- $155.30
Price performance
| Period | Change |
|---|
| 1 day | -1.00% |
| 5 days | -5.51% |
| 1 month | -1.08% |
| 3 months | +4.36% |
| 6 months | +120.28% |
| Year to date | +46.32% |
| 1 year | +45.08% |
| 3 years | -24.14% |
| 5 years | -6.64% |
| 10 years | +113.49% |
| All time | +3755.76% |
Profitability and growth
- Return on equity
- 6.70%
- Return on invested capital
- 24.05%
- Return on assets
- 2.43%
- Return on capital employed
- 8.30%
- Gross margin
- 14.00%
- Net margin
- 0.92%
- EBITDA margin
- 2.68%
- Revenue growth
- 10.11%
- Net income growth
- -1.57%
- Free cash flow growth
- -84.32%
Cash flow and balance sheet
- Free cash flow yield (TTM)
- 2.83%
- Current ratio
- 1.77x
- Net debt to EBITDA
- -2.49x
Latest reported year
- Period end
- 2025-12-31
- Fiscal year
- 2025
- Revenue
- $129.66B
- Cost of revenue
- $111.51B
- Gross profit
- $18.15B
- EBITDA
- $3.48B
- Net income
- $1.19B
- Earnings per share
- $9.87
- Shares outstanding
- 120.45M
Income statement by year
| Period end | Revenue | Gross profit | Net income | EPS |
|---|
| 2025-12-31 | $129.66B | $18.15B | $1.19B | $9.87 |
| 2024-12-31 | $117.76B | $16.26B | $1.21B | $10.01 |
| 2023-12-31 | $106.37B | $17.20B | $2.49B | $20.09 |
| 2022-12-31 | $92.87B | $16.47B | $2.81B | $22.20 |
| 2021-12-31 | $83.06B | $13.27B | $2.93B | $22.79 |
| 2020-12-31 | $77.16B | $15.04B | $3.37B | $25.47 |
| 2019-12-31 | $64.89B | $10.57B | $2.71B | $20.20 |
| 2018-12-31 | $56.91B | $10.63B | $1.68B | $12.24 |
| 2017-12-31 | $53.77B | $10.83B | $2.45B | $16.94 |
| 2016-12-31 | $54.38B | $8.91B | $614.00M | $4.11 |
Margins and returns by year
| Period end | Gross margin | Net margin | Return on equity | Return on capital |
|---|
| 2025-12-31 | 14.00% | 0.92% | 6.70% | 24.05% |
| 2024-12-31 | 13.81% | 1.02% | 7.34% | 27.80% |
| 2023-12-31 | 16.17% | 2.34% | 15.25% | 47.75% |
| 2022-12-31 | 17.74% | 3.02% | 18.26% | 40.22% |
| 2021-12-31 | 15.97% | 3.53% | 18.21% | 20.90% |
| 2020-12-31 | 19.49% | 4.36% | 24.53% | 100.93% |
| 2019-12-31 | 16.29% | 4.17% | 22.49% | 77.73% |
| 2018-12-31 | 18.67% | 2.96% | 16.56% | 19.51% |
| 2017-12-31 | 20.14% | 4.55% | 24.87% | 25.09% |
| 2016-12-31 | 16.39% | 1.13% | 5.75% | 7.99% |
Cash and debt by year
| Period end | Cash | Debt |
|---|
| 2025-12-31 | $19.90B | $12.37B |
| 2024-12-31 | $20.43B | $11.14B |
| 2023-12-31 | $21.32B | $10.21B |
| 2022-12-31 | $18.94B | $9.03B |
| 2021-12-31 | $16.59B | $10.54B |
| 2020-12-31 | $17.23B | $6.06B |
| 2019-12-31 | $15.03B | $4.97B |
| 2018-12-31 | $2.34B | $4.38B |
| 2017-12-31 | $4.04B | $4.77B |
| 2016-12-31 | $3.88B | $3.79B |
Free cash flow by year
| Period end | Free cash flow | Stock-based compensation |
|---|
| 2025-12-31 | $375.00M | $241.00M |
| 2024-12-31 | $2.39B | $207.00M |
| 2023-12-31 | $2.98B | $175.00M |
| 2022-12-31 | $3.45B | $216.00M |
| 2021-12-31 | $920.00M | $180.00M |
| 2020-12-31 | $4.67B | $181.00M |
| 2019-12-31 | $4.55B | $163.00M |
| 2018-12-31 | $1.56B | $137.00M |
| 2017-12-31 | $3.53B | $157.00M |
| 2016-12-31 | $1.41B | $115.00M |
Dividend history
- Most recent payment
- 2026-06-26
- Paid in the last twelve months
- $3.54
| Payment date | Dividend per share |
|---|
| 2026-06-26 | $0.89 |
| 2026-03-27 | $0.89 |
| 2025-12-26 | $0.89 |
| 2025-09-26 | $0.89 |
| 2025-06-27 | $0.89 |
| 2025-03-28 | $0.89 |
| 2024-12-31 | $0.89 |
| 2024-09-30 | $0.89 |
Investor relations
Next earnings report
- Next confirmed report
- 2026-11-06
Past earnings dates
| Reported | Fiscal period | EPS estimate |
|---|
| 2026-07-29 | Jun/2026 | $6.22 |
| 2026-04-29 | - | - |
| 2026-02-11 | - | - |
| 2025-11-05 | - | - |
| 2025-07-30 | - | - |
| 2025-04-30 | - | - |
| 2025-02-11 | - | - |
| 2024-10-30 | - | - |
Filings and sources
- Company website
- humana.com
- SEC filings
- 10-K, 10-Q and 8-K on EDGAR
- Earnings calendar
- All upcoming reports
Similar companies
UnitedHealth Group Inc (UNH) · CVS Health Corp (CVS) · Elevance Health, Inc. (ELV) · Cigna Group (CI) · Molina Healthcare, Inc. (MOH) · Vertex Pharmaceuticals Inc (VRTX) · Regeneron Pharmaceuticals, Inc. (REGN) · Moderna, Inc. (MRNA)
All Healthcare companies
Understanding these figures
Price-to-earnings ratio · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart
Explore
Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades